Drugs in Virtual Enterprise - DRIVE

Objectives

To improve the quality of patient care and the safety of the Patient by:

  • reducing drug administration errors - developing a safer healthcare system
  • reducing supply chain costs - developing a smarter healthcare system

Focus Point

The IT systems developed in DRIVE focus on three key areas of healthcare optimization:

  • Clinical Process: represents the drug processes within the hospital directly or indirectly aimed at the Patient's helath state from the admission until discharge
  • Suppy Chain: represents the flow process of the pharmaceutical products and information used, from the manufacturer to point of use (Patient's bedside)
  • Trust: represents the stakeholder requirements for the protection of critical assets: personal clinical records, professional accountability, enterprise value chain and privacy within the entire business model

Schedule

1999 - 2002

Partners

  • Fondacione Centro San Raffaele Del Monte Tabor (HSR), Italy

  • AstraZeneca

  • GlaxoSmithKline

  • ATOS Origin, France & Italy

  • FAVERO Health Projects, Italy

  • Politechnico di Milano, Italy

  • Gdansk University of Technology, Poland

  • Karolinska Insitutet, Sweden

  • Joint Research Centre